(Q43231277)

16 November 2017

The study of efficacy of lamivudine in patients with severe acute hepatitis B. (English)

1 reference

16 November 2017

1 reference

Jian-Wu Yu

1

1 reference

16 November 2017

Li-Jie Sun

2

1 reference

16 November 2017

Yong-Hua Zhao

3

1 reference

16 November 2017

Peng Kang

4

1 reference

16 November 2017

Shu-Chen Li

5

1 reference

16 November 2017

3 December 2009

1 reference

Digestive Diseases and Sciences

16 November 2017

1 reference

16 November 2017

55

1 reference

16 November 2017

3

1 reference

16 November 2017

775-783

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-009-1060-5

16 November 2017

0 references

cites work

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1060-5

Lamivudine treatment for severe acute HBV hepatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1060-5

Early indicators of prognosis in fulminant hepatic failure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1060-5

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection

21 January 2018

1 reference

12 December 2020

Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection

1 reference

12 December 2020

Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment

1 reference

12 December 2020

A randomized controlled trial of lamivudine to treat acute hepatitis B

1 reference

12 December 2020

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

1 reference

12 December 2020

Management of hepatitis B: summary of a clinical research workshop

1 reference

12 December 2020

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.

1 reference

12 December 2020

[Lamivudine therapy in patients with severe acute hepatitis B]

1 reference

12 December 2020

Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis

1 reference

12 December 2020

Effectiveness and long-term outcome of lamivudine therapy for acute hepatitis B

1 reference

12 December 2020

Lamivudine treatment for acute severe hepatitis B: a pilot study

1 reference

12 December 2020

Lamivudine in the treatment of acute hepatitis B

1 reference

12 December 2020

The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment

1 reference

12 December 2020

[Diagnostic and treatment guidelines for liver failure]

1 reference

12 December 2020

Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation

1 reference

12 December 2020

Lamivudine treatment improves the prognosis of fulminant hepatitis B.

1 reference

12 December 2020

10.1007/S10620-009-1060-5

Identifiers

DOI

1 reference

16 November 2017

1 reference